Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPHARM Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 23.66 | 2.37 | 23.66 | 23.66 | 18.66 |
| Share application money | - | 55.36 | - | - | 4.00 |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 33.11 | -6.78 | -2.86 | 16.87 | 22.32 |
| Loan funds | |||||
| Secured loans | 2.50 | 3.02 | 46.23 | 44.37 | 80.14 |
| Unsecured loans | - | - | - | 2.17 | 2.24 |
| Total | 59.27 | 53.96 | 67.02 | 87.06 | 127.36 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 79.57 | 74.09 | 72.87 | 72.54 | 72.41 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 43.60 | 39.12 | 35.85 | 32.60 | 29.09 |
| Net block | 35.97 | 34.97 | 37.02 | 39.94 | 43.32 |
| Capital work-in-progress | 0.83 | 0.21 | - | - | - |
| Investments | - | - | 1.43 | 1.43 | 18.33 |
| Net current assets | |||||
| Current assets, loans & advances | 49.67 | 35.88 | 82.19 | 86.15 | 105.50 |
| Less : current liabilities & provisions | 27.19 | 17.10 | 53.62 | 40.45 | 39.79 |
| Total net current assets | 22.47 | 18.78 | 28.57 | 45.70 | 65.71 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 59.27 | 53.96 | 67.02 | 87.06 | 127.36 |
| Notes: | |||||
| Book value of unquoted investments | - | - | 1.43 | 1.43 | 18.33 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | 0.46 | 0.29 |
| Number of equity sharesoutstanding (Lacs) | 236.56 | 23.66 | 236.56 | 236.56 | 186.56 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis